Those who are eligible to file a claim for 23andMe's settlement include anyone who was a customer with 23andMe anytime ...

The genetic testing company is addressing the fallout from a 2023 credential stuffing attack. Here's how to protect yourself.

It's not too late to delete your 23andMe data. Twenty-seven states and the District of Columbia sued the DNA testing company on Monday to prevent it from selling customers' genetic data without ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

23andMe, the genetic testing giant once valued in the billions, is now navigating Chapter 11 bankruptcy and notifying millions of current and former customers that they may be eligible to file claims ...

23andMe helped 15 million users around the world answer the question we all share: Where did I come from?

Genetic testing firm 23andMe is set to be acquired by drug company Regeneron Pharmaceuticals following its bankruptcy in March, the companies announced on Monday, May 19. Regeneron purchased the ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...

23andMe, a distressed genetic testing company that filed for bankruptcy this year, has received another potential lifeline. A bankruptcy judge approved the sale of the company’s assets and business ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday. 23andMe filed for Chapter 11 bankruptcy protection in March. Last month, ...

23andMe has 80 job openings posted on its website, offering insight into the popular direct-to-consumer DNA testing company’s focus and areas for growth. Antonio Regalado, senior writer for ...